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075: Prenatal and Postnatal diagnosis for Beta
thalassemia and sickle cell anemia
R. Angalena, S. M. Naushad, A. Radha Rama Devi, B. Ashwin Dalal
Centre for DNA Fingerprinting and Diagnostics, ECIL Road,
Nacharam, Hyderabad 500 076, India
The current study aims to summarize the data obtained from screening of
families with probands on regular transfusions and carriers having ele-
vated Hemoglobin A2 levels for Beta Thalassemia and Sickle cell anemia
using 155 cases for Postnatal diagnosis and 34 for Prenatal diagnosis.
Molecular analysis was done using PCR followed by Reverse Dot blot
analysis and sequencing. Of the 34 cases for Prenatal diagnosis, 9 were
found to be normal for RDB and sequencing, 15 were heterozygous for
one of the seven common mutations, 8 were homozygous mutant and 2
were compound heterozygous. VNTR analysis using 16 microsatellite
markers were done to rule out maternal contamination. Of the 155 cases
(includes probands and parents) for which molecular testing was done
showed 40 were normal, 82 heterozygous and 33 homozygous for one of
the 7 common mutation by RDB. IVS1-5(G-C) being the most com-
mon,as reported earlier in the descending the order of IVS1-5 (G-C),
FS41/42, HbS, FS 8/9, Codon 15, HbE and 619 bp deletion. We present
here a unique case referred to our centre, a couple who came to our clinic
at 12 weeks of her gestation. The father showed elevated levels of
Hemoglobin A2 in HPLC indicative of the presence of a hemoglobin
variant, which was suspected to be HbE. Proband was not alive and so
there was no information of the mutations in that family. RDB showed a
normal picture in both the parents (including HbE) as well as in the
Chorion villus sample. On sequencing both the parents showed FS
Codon5 (-CT) mutation and normal sequence in fetus. FS Codon 5 (-CT)
is a rare mutation which accounts for less than 1% of mutations in India. In
addition, the father was heterozygous for Hemoglobin D Iran, which led
to a similar picture to HbE. The mother was advised to continue her
pregnancy. This highlights the need to increase awareness among public
regarding the importance of genetic testing in proband so that prenatal
diagnosis can be done in subsequent pregnancies.
076: CC2D1A is involved in autosomal recessive
non-syndromic mental retardation in a Pakistani Family
1Muhammad Ansar, 1Muzammil Ahmad Khan,
2Muhammad Arshad Rafiq, 1Wasim Ahmad
1Quaid-i-Azam University, Department of Biochemistry, Faculty
of Biological Sciences, QAU, Islamabad, Pakistan, 2The Centre
for Applied Genomics, Hospital For sick Childern, Program in
Genetics and Genomic Biology, Department of Molecular and
Medical Genetics, University of Toronto, MaRS Centre, Toronto,
Ontario, M5GIL7, Canada
Mental retardation is the most frequent handicap among children and
young adults affecting 1–3% of the general population. To date of 11
loci, with linkage to nonsyndromic autosomal recessive mental
retardation (NSARMR), only four genes have been found with
associated mutations. The MRT3 locus was initially mapped in
families with NSARMR to an interval of 2.4 Mb and is caused by
deletion of CC2D1A gene. We have studied a three generation
Pakistani family with three affected individuals. The affected indi-
viduals of the family segregate NSMR and have psychomotor
developmental delay in childhood. None of the diseased individual
reveals the presence of autism spectrum disorders or seizures. The
DNA samples from five family members, including three affected
females were used for genotyping of microsatellite markers linked to
known MRT (MRT1-11) loci. Analysis of the results indicates link-
age of the studied family to MRT3 (19p13.12) locus with a maximum
two-point LOD score of 2.08 at markers D19S892 and D19S556. The
same markers yielded multipoint LOD score of 2.64. Sequencing of
CC2D1A gene is in progress to identify the mutation responsible for
NSARMR in Pakistani family.
077: Molecular analysis in pediatric Wilson’s disease:
13 novel mutations
Prahlad Balakrishnan, Madhulika Kabra, Veena Kalra,
Narender Kumar Arora
All India Institute of Medical Sciences, Genetic Unit, Department of
Pediatrics, Ansari Nagar, New Delhi, India
Objectives: WD (Wilson’s disease) is an autosomally inherited defect
characterized by the accumulation of copper in liver, brain and other vital
organs. This occurs primarily due to mutations in the P-type ATP7B gene
for the trans-Golgi membrane protein resulting in the accumulation of
copper. The main aim of our study was to identify common mutations
causing WD in pediatric patients of Asian-Indian origin.
Methods: Fifty nine pediatric patients from 52 unrelated families were
enrolled for this study after obtaining written informed consent.
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Diagnosis of WD was based on mandatory clinical and biochemical
analysis. Mutational screening was carried out using a combination of
Single Strand Conformation Polymorphism (SSCP) and Conforma-
tion Sensitive Gel Electrophoresis (CSGE). Sequencing was
performed for samples showing mobility shift. Screening was done
for all the exons (including the flanking splice sites) as well as the
promoter region. Detected sequence changes were also looked for in
60 unrelated controls.
Results: Causative mutations were identified in 49 out of 59 (83.05%)
samples studied. None of these mutations were detected in controls. A
total of 24 different mutations were found, including 13 missense, 3
nonsense, 2 splice site, 5 deletions and 1 insertion mutation. Thirteen
(54.1%) of the detected mutations were novel. Maximum numbers of
mutations were identified in exon 2 followed by exon 14.
Conclusion: Commonly reported mutations H1069Q and R778L
(from the Caucasian as well as the Asian non-Indian population) were
not detected in this study and a very heterogeneous spectrum of
mutations emerged. Our preliminary study indicates that there is a
possibility that exons 2 (p.Q271X) and 14 (p.G1061E) mutations
maybe very common mutations in the Indian population but this
assumption has to be supported by large multicentric studies (which
would be representative of the ethnic heterogeneity of the Indian
population) before arriving to a definite conclusion.
078: Modifier gene mutations in Beta thalassemia
Gargi Bhattacharya, Papai Roy, Uma B. Dasgupta
Department of Bio-Physics and Molecular Biology, University
of Calcutta, 92, A.P.C Road, Kolkata-700009, India
Beta thalassemia is the most prevalent monogenic hemoglobin disorder
and causes significant mortality. It is also characterized by wide vari-
ation in phenotypes, underscoring the contribution of modifier genes.
Excess unpaired a-chain is responsible for much of the dyserythropo-
esis and hemolysis in b-thalassemia and determinants, which reduce
the amount of free a-chain, reduce the severity. Hence knowledge of
a-globin gene mutations and deletional b-globin cluster mutations,
which elevate the level of HbF in adult stage, are essential to evaluate
b-intermedia cases. We present the molecular details of these deter-
minants found in patients of eastern part of India and Bangladesh.
Deletional a-globin mutations are detected by standard method and
are present at frequencies of 16, 5 and 12.5% for 3.7, 4.2 kb and SA
deletion respectively in a-thalassemia patients. SEA and a new dele-
tion KOL have also been detected. Among non deletional a-globin
mutations the polyadenylation (poly A) signal mutation AAT
AAA[AATA–, Hb Sun Prairie and Koya Dora are found in appre-
ciable numbers. Using PCR-based assays designed for easy screening
of patients, the polyadenylation mutation is detected very frequently in
our population. Out of 77 putative a-thalassemia patients, nine carried
the poly A signal mutation and four were homozygotes; the allele
frequency was 8.5%. Out of 13 b-thalassemia intermedia patients,
three were positive for this mutation. Inheritance of certain cis or trans
acting mutations of b-globin cluster increases the ability of adult
erythroblasts to synthesize c-globin chains. Several deletions and point
mutations can precipitate the condition in a pancellular way, and the
value of HbF may get raised above 90%. We studied 18 probands with
raised HbF, ranging between 9.2 and 97.2%. Of these, 17 chromo-
somes bearing the Asian Indian inversion-deletion have been
identified, from nine families. Three persons from two families had
HPFH-3 and one person had the Asian deletion. The clinical profile of
the entire patient group mentioned above will be presented. Study of
heterocellular or swiss type HPFH revealed that the Senegal haplotype
and the XmnI RFLP is linked to high HbF phenotype but significance
did not reach the desired 0.05 level (p [ 0.063).
079: Not so simple! Hemophilia B as a
quasi-quantitative condition with mutations showing
variable penetrance
1Sreenivas Chavali, 1Rubina Tabassum, 1Amitabh Sharma,
2Saurabh Ghosh, 1Dwaipayan Bharadwaj
1Functional Genomics Unit, Institute of Genomics and Integrative
Biology, CSIR, Delhi-110 007, India, 2Human Genetics Unit, Indian
Statistical Institute, Kolkata-700 108, India
Hemophilia B (MIM# 306900), an X-linked bleeding disorder
caused by mutations in human coagulation factor IX, can be clas-
sified as severe, moderately severe and mild based on the plasma
levels of factor IX among affected individuals with respect to nor-
mal factor IX activity assayed in the patients’ plasma (\1, 2–5, 6–
30%, respectively). Recently, we identified hemophilia B to be a
disease with mutations showing clinical variation. Here, we have
analyzed the differences in sequence and structural properties among
identical mutations with varying phenotypes (IMVPs) by comparing
with mutations with uniform phenotypes (MUPs), with recurring
reports in Haemophilia B mutation database derived based on
clinical cut-offs. IMVPs (n = 51) occur in less conserved mutant
sites with more tolerated substitutions compared to MUPs
(n = 100), though no significant differences were observed in
structural properties. A preponderance of CpG site mutations and
Arg as the mutated residue in IMVPs compared to Cys in MUPs
was observed. Hence, a CpG site substitution at less conserved Arg
site might have an increased propensity of expressing variable
phenotypes. Further, we considered clotting activity as continuous
phenotype and investigated the variation expressed by these mis-
sense mutations. We derived mean deviation about the geometric
mean and classified the mutations by unsupervised learning into
three clusters viz., cluster 1 (n = 11), 2 (n = 33) and 3 (n = 157)
with centroids 9.17, 4.00 and 0.45, respectively. As the allelic
spectrum encompasses mutations that show least phenotypic varia-
tion as well as those showing phenotypic plasticity, we establish
hemophilia B as a quasi-quantitative condition characterized by
variable penetrance, relocating it from the section of simple
monogenic diseases into a space that marks the conceptual contin-
uum of Mendelian to complex diseases. Mutations showing
phenotypic plasticity were characterized by relatively less conserved
mutant sites and more tolerated conservative substitutions. Based on
this study and available literature we speculate that modifier genes
at other loci, epigenetic interactions and environment may serve
individually or cumulatively to bring about the phenotypic hetero-
geneity. Certain mutations have been consistently reported to cause
mild phenotype, calling for a check in indiscriminate termination of
fetuses with such mutations following prenatal diagnosis.
080: Mutational analysis of PMP22, MPZ, GJB1
and EGR2 genes in Charcot-Marie-Tooth Neuropathy
(type1) patients from Bashkortostan Republic of Russia
1Irina Gilyazova, 1Irina Khidiyatova, 1Elvira Latypova,
2Nataliya Krupina, 2Rim Magzhanov, 1Elza Khusnutdinova
1Institute of Biochemistry and Genetics, Prospekt Oktyabrya, 71,
Russia, 2Bashkir State Medical University, Lenin Street, 3, Russia
Charcot-Marie-Tooth (CMT) disease or hereditary motor and sensory
neuropathy (HMSN) is a clinically and genetically heterogeneous dis-
order of peripheral nervous system. The HMSN frequency in
Bashkortostan Republic (BR) is 10.3:100000. HMSN type I is prevalent
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in Bashkortostan. We examined CMT1A duplication of 17p11.2-p12,
mutations of PMP22, MPZ (P0), GJB1 (Cx32) and EGR2 genes in 131
unrelated patients. Based on electrophysiological criteria, 67 of 131
patients were diagnosed as CMT1, 9 patients—as CMT2, and 55
patients had not electrophysiological data. The CMT1A duplication
was found in 26.7% of 131 CMT patients. In PMP22 gene we deter-
mined one nucleotide change—c.309-29 G[A, which haven’t been
described previously. In the families without PMP22 duplications, we
revealed Ser88Ley (C263G) mutation in one patient (0.8%), and syn-
onymous nucleotide change 714C[T (Ser238Ser) in two patients
(1.6%) in the MPZ gene. We detected 4 missence-mutations in the
GJB1 gene in 18 of 131 unrelated patients (13.7%), including 1 novel
mutations:Pro87Ala (c.259C[G), found at a frequency of 10%
among HMSN patients, Arg22Gln (c.65G[A)—2.98%, Arg15Gln
(c.44G[A)—1.5% and Thr86Ile (c.257C[T)—0.8%. The frequent
mutation Pro87Ala was revealed in patients of Bashkir ethnic origin. It
was linked to one and the same haplotype that evidences about founder
effect. No changes were revealed in EGR2 gene in HMSN patients.
Thus, specific spectrum of mutations was detected in HMSN patients
from Bashkortostan that contributes to development of optimal DNA
diagnostics for this region.
081: Novel mutations in FRMD7 in Russian families
with X-linked congenital motor nystagmus
Svetlana Gudzenko, Valeriy Fedotov, Rena Zinchenko,
Anna Abrukova, Elena Osipova, Alexander Polyakov
Research Centre for Medical Genetics, Moscow, Moscworechie
str., 1, Russia
X-linked congenital motor nystagmus is a common inherited oculo-
motor disorder characterized by repetitive uncontrollable ocular
oscillations, unassociated with a number of ocular or neurological
diseases with onset typically at birth. The loci for X-linked CMN have
been mapped to Xp11.3-p11.4 and Xq26-q27 (NYS1). Three more loci
have been described for autosomal-recessive and autosomal-dominant
form of CMN without any gene identification. The molecular char-
acterization of NYS1 has been solved by Tarpey et al., who identified
mutations in FRMD7, a gene with un-known function. The aim of our
research was searching for FRMD7 mutations in three Russian fami-
lies, who had already shown the linkage with Xq26-q27 locus, and 26
sporadic unrelated cases with X-linked CMN. Sequencing analysis of
all exons and intron-exon junctions of FRMD7 was performed in 29
affected individuals. We identified five novel, previously unreported
mutations (three missense, one nonsense and a small deletion) in
FRMD7: c.47T[C (Phe16Ser), c.804G[T (Trp268Cys), c.657G[T
(Lys219Asn), c.1524G[A (Trp508Stop), c.1492delT, and one known
mutation c.902A[G (Tyr301Cys). The mutations c.47T[C (Phe16-
Ser), c.1524G[A (Trp508Stop) and c.1492delT were identified in all
three familial cases; the mutations c.804G[T (Trp268Cys), c.657G[T
(Lys219Asn) and c.902A[G (Tyr301Cys) were observed in four
sporadic cases (the mutation c.657G[T (Lys219Asn) was identified in
two unrelated patients). Thus the results of our study confirm the role
of FRMD7 in the pathogenesis of X-linked CMN.
082: Molecular screening approach for identification
of mutations causing familial hypercholesterolaemia
in Western Australia
1Amanda J. Hooper, 1Lan T. Nguyen, 1,2John R. Burnett,
1,3Frank M. van Bockxmeer, 4on behalf of the FHWA Pilot Program
1Department of Core Clinical Pathology and Biochemistry, PathWest
Laboratory Medicine WA, Royal Perth Hospital, Wellington Street,
Perth WA 6000, Australia, 2School of Medicine and Pharmacology,
University of Western Australia, 35 Stirling Highway, Crawley WA
6009, Australia, 3School of Pathology and Laboratory Medicine,
University of Western Australia, 35 Stirling Highway, Crawley WA
6009, Australia, 4FHWA Clinic, Royal Perth Hospital, Wellington
Street, Perth WA 6000, Australia
It is well established that elevated plasma concentrations of low density
lipoprotein (LDL) cholesterol are associated with increased risk of
cardiovascular disease. Autosomal dominant familial hypercholeste-
rolaemia (FH) is one of the most common human diseases caused by
mutations in a single gene, affecting some 10 million people world-
wide. FH is characterised by high levels of circulating LDL caused by
reduced clearance of LDL from plasma by the LDL-receptor pathway,
leading to premature coronary heart disease (CHD). The majority of
FH is caused by mutations in the LDL-receptor (LDLR) gene; over 800
have been described. Of the estimated 40,000 cases of FH in Australia,
80% are undiagnosed and less than 10% are being adequately treated.
Treatment with statins is highly effective in lowering plasma LDL-
cholesterol. The FH Western Australia (FHWA) pilot program has
been established to identify and treat individuals with FH in WA, by
cascade screening from index cases. A genetic screening protocol has
been designed that consists of three stages: (1) detection of 20 com-
monly occurring mutations by an amplification refractory mutation
system (ARMS), (2) detection of deletions/duplications by multiplex
ligation-dependent probe amplification (MLPA) and (3) exon-by-exon
sequencing of the LDLR gene. Using this approach, a mutation was
identified in 36 of 50 consecutive index patients enrolled in FHWA.
Eleven patients carried mutations that were detected by ARMS, and six
carried mutations detected by MLPA, indicating that almost half of FH
index patients carrying a mutation could be identified without the need
for exon-by-exon sequencing. In summary, we present a cost-effective
genetic screening strategy for FH and preliminary data for the FHWA
pilot program. DNA test results will be useful for cascade screening
from FH index cases, leading to early detection of other previously
undiagnosed family members and enabling early intervention and
prevention of premature CHD and death.
083: Prenatal diagnosis of single gene disorders:
10 years experience from a referral center
1Madhulika Kabra, 1Sadhna Arora, 1Madhumita Roychoudhury,
1Shivram S Shastri, 1R Vijaya, 1Monika Tiwari, 1Sandeepa Chauhan,
1Pallavi Shukla, 2Prahlad BalaKrishnan, 2Neerja Gupta,
2Deepika Deka, 2Alka Kriplani
1Genetics Unit, Department of Pediatrics, All India Institute
of Medical Sciences, Ansari Nagar, New Delhi 110029, India,
2Department of Obstetrics and Gynecology, All India Institute
of Medical Sciences, Ansari Nagar, New Delhi 110029, India
In the absence of treatment for most life limiting single gene disorders,
families opt for prenatal diagnosis (PND) and selective termination of
affected fetuses for preventing birth of affected babies. Direct muta-
tion testing and linkage analysis (in the absence of known mutations)
can be used to track the affected allele(s). We present our experience
of PND of single gene disorders in last 10 years. In most cases fetal
tissue used was chorionic villus biopsy. The most common referral
was for prenatal diagnosis of b thalassemia and other hemoglobin-
opathies for which we have offered PND in 915 at risk pregnancies
using amplification refractory mutation system (ARMS) or linkage
(6.71%) and were able to give confirmed results in 97.5% of cases.
About 20% fetuses were affected. Spinal Muscular atrophy (SMA) is
probably the second most common autosomal recessive (AR) single
gene disorder after thalassemia in India. We have performed prenatal
testing for SMA (looking for homozygous deletion of exon 7 of SMN
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gene) in 125 families out of which 32 fetuses (25.5%) were affected.
Another AR disorder which was thought to be rare in India is Cystic
fibrosis (CF). We were able to delineate a very different mutational
spectrum including novel mutations in CF patients and offer PND to
29 families out of which 6 fetuses were affected. Common X linked
disorders referred for PND included Hemophilia A/B and Duchenne
Muscular dystrophy (DMD). For Hemophilia (A and B) about 100
families were offered PND, mostly by linkage and 31 babies were
affected. For DMD 176 PND were done (multiplex PCR and linkage)
detecting 37 affected babies. Megalencephalic leukodystrophy, prob-
ably the commonest cause of Leukodystrophy in Indians is caused by
mutation, c.135_136insC. We have tested about 25 families and
offered PND in three families. PND for some rare disorders has also
been offered. We do not have follow up of the pregnancy outcome for
all tested fetuses but available data shows almost 100% accuracy. We
feel that there is a felt need for PND amongst at risk families and there
should be more centers equipped with molecular diagnostic and pre-
natal diagnostic facilities in our country.
084: Mutational analysis of ATP7B gene and genotype-
phenotype correlation in Wilson’s disease patients
from the Volga-Ural region of Russia
1A. S. Karunas, 2A. R. Magzhanova, 2R. V. Magzhanov,
1E. K. Khusnutdinova
1Insitute of Biochemistry and Genetics of Ufa Science Center,
Russian Academy of Science, Prospect Oktyabrya, 71, Ufa, 450054,
Russia, 2Bashkirian State Medical University, Lenin Street, 3,
Ufa, 450000, Russia
Wilson disease (WD) is an autosomal recessive disorder of copper
transport, caused by mutations in the ATP7B gene (13q14.3-q21.1)
encoding a copper-transporting P-type ATPase. Defects in ATP7B
lead to copper storage in different organs and tissues, principially in
the liver and in the brain. The disease manifests as progressive liver
degeneration and neurological impairment, frequently with kidney
malfunction. The clinical symptoms and age at onset of Wilson dis-
ease are highly variable. The purposes of this research were the
detection of disease-causing mutations and analysis of correlation
between phenotype and genotype. We examined 43 Wilson’s disease
patients from 32 WD families of various origins from the Volga-Ural
region of Russia (Tatars, Russians, Bashkirs and mixed origins). The
mutational screening of ATP7B was performed by SSCP-analysis and
sequencing of shifted exons. We have identified three novel mutations
(p.A718P, p.L1057P, p.K1315_R1316delinsE) and six mutations that
had been previously described (c.2298_2299insC, p.E1064K,
p.H1069Q, c.3400delC, c.3559+1G[T, p.L1305P). The most com-
mon mutation, p.H1069Q, was observed in 46.88% of the WD
chromosomes. The frequency of this mutation in Russians was
50.00%, Bashkirs—44.4%, Tatars—40.9%. The patients homozygous
for the H1069Q mutation had more frequently neurologic presenta-
tions and a later age of symptoms onset than H1069Q heterozygotes
and patients without the H1069Q mutation. One of the novel muta-
tions, p.K1315_R1316delinsE, was found with an relatively high
frequency in Bashkirs (22.2%) and Tatars (18.1%). One patient was
homozygous for p.K1315_R1316delinsE mutation and five patients
were heterozygotes. The patients with p.K1315_R1316delinsE had
more severe clinics with early manifestation and hard liver disorders.
Two Russian patients were heterozygous carriers of the novel muta-
tion p.L1305P and one Russian patient was the p.A718P
heterozygote. The mutation p.E1064K was determined mainly in
Russians—in 15% of the WD chromosomes. The remaining muta-
tions were detected rare and limited to one or two patients. This study
has expanded our knowledge on the spectrum of mutations in the WD
gene in patients from Volga-Ural region of Russia and has found
correlation between type of mutation and clinical manifestations.
085: Primary Immunodeficiency disease database:
A discovery tool for the genomics research
1Shivakumar Keerthikumar, 1Rajesh Raju,
1,2Kumaran Kandaswamy, 3Atsushi Hijikata,
1,3Shubhashri Ramabadran, 1,3Lavanya Balakrishnan,
1Mukhtar Ahmed, 1Sandhya Rani, 1Lakshmi Dhevi Nagarajha Selvan,
1Devi Sundhari Somanathan, 1Somak Ray, 1Mitali Bhattacharjee,
1Sashikanth Gollapudi, 1,3,4Osamu Ohara, 1,2Akhilesh Pandey,
1,3Sujatha Mohan
1Insitute of Bioinformatics, Bangalore 560066, India, 2The Johns
Hopkins University School of Medicine, Baltimore, MD 21205,
United States of America, 3Riken, Research Center for Allergy and
Immunology, Yokohama, Kanagawa 230-0045, Japan, 4Kazusa DNA
Research Institute, Kazusa-Kamatari, Kisarazu, Chiba 292-0818,
Japan
Resource of Asian Primary Immunodeficiency diseases (RAPID) is a
web-based compendium of molecular alterations in primary immu-
nodeficiency diseases. The main objective of this database is to
provide detailed and user-friendly information of genes and proteins
involved in primary immunodeficiency diseases along with other
pertinent information about signaling pathways, protein-protein
interactions, mouse studies and their gene expression profile in dif-
ferent cells of the immune system. All this information is well
organized and connected such that RAPID should serve as a discovery
tool for prediction of candidate primary immunodeficiency disease
genes, a useful feature for immunologists, physicians and researchers.
RAPID also hosts mutation viewer tool for the visualization of mapped
sequence variations. Using bioinformatics analysis, all primary
immunodeficiency disease genes have been mapped to immune sig-
naling pathways from Kyoto Encyclopedia of Genes and Genomes
(KEGG) pathway database, interaction networks from Human Protein
Reference Database (HPRD), microarray expression profiles across
different study from Gene Expression Omnibus (GEO), Array
Express, Stanford Microarray Database (SMD) and also mapped to
mouse studies from Mouse Genome Informatics (MGI) for the rep-
resentation of allele based phenotypes and anatomical systems
affected for the available PID genes. With such varied data available
so far for all the known primary immunodeficiency disease genes,
RAPID would also serve as a connecting link between the phenotype
and the genotype.
086: DNA-diagnostics of choroideremia in Russian
family
Olga Khlebnikova, Svetlana Gudzenko, Alexander Polyakov
Research Centre for Medical Genetics, Russian Federation,
Moscow, Russia
Choroideremia is a congenital X-linked ocular disease characterized
by the degeneration of the choriocapillaris, the retinal pigment epi-
thelium and the photoreceptor of the eye. The disorder leads to the
progressive loss of vision beginning at an early age resulting from
the complete atrophy of the choroid and retina. The CHM gene
responsible for choroideremia, is located on Xq21.2, contains 15
exons and encodes a protein, the Rab escort protein-1 (REP1), which
is involved in membrane trafficking. Currently, there are about 110
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mutations in CHM gene, and these are all nonsense, frameshift or splice
site mutations leading to choroideremia. The purpose of our study was
elaboration of DNA-diagnostics of choroideremia in affected Russian
patient. Sequencing analysis of all exons and intron-exon junctions of
CHM in affected man showed a previously described nonsense muta-
tion Arg253Stop (c.757C[T) in exon 6 of CHM. Restriction analysis
performed in a sister of the patient, who has small clinical presentations
of choroideremia, detected mutation Arg253Stop (c.757C[T) in het-
erozygous state. Thus the given DNA-analysis results revealed a
disease-causing mutation Arg253Stop (c.757C[T) and confirm the
diagnosis ‘choroideremia’ in the clinical case.
087: Molecular genetics of primary microcephaly
in Indian families
1Arun Kumar, 1M. R. Duvvari, 2S. H. Blanton, 3S. C. Girimaji
1Indian Institute of Science, Dept. of Molecular Reproduction,
Development and Genetics, Bangalore, India, 2Miami Institute of
Human Genomics, University of Miami, Miami, United States of
America, 3National Institute of Mental Health and Neurosciences,
Department of Psychiatry, Bangalore, India
Microcephaly (small head) is defined as a condition in which the head
circumference of an affected individual is [3 SD below the popula-
tion age and sex related mean. The small cranial capacity results from
underlying hypoplasia of the cerebral cortex rather than abnormal
development of the overlying skull. Primary microcephaly (MCPH;
OMIM 251200) is a distinct subtype that is defined by the absence of
associated malformations and of secondary or environmental causes.
It is inherited as an autosomal recessive trait. Patients with MCPH
have mild to severe mental retardation but without any other neuro-
logical deficits. It has an incidence of 1/30,000–1/250,000 live births
in western populations. The actual incidence of MCPH is not known
in India, but it could be higher in south Indian states of Karnataka,
Andhra Pradesh, Kerala and Tamil Nadu where *33% of marriages
are consanguineous. It is a genetically heterogeneous disorder with
six known loci: MCPH1-MCPH6. So far, genes for MCPH1
(MCPH1), MCPH3 (CDK5RAP2), MCPH5 (ASPM) and MCPH6
(CENPJ) loci have been identified. We have ascertained a total of 42
families with MCPH from the states of Karnataka, Andhra Pradesh
and Tamil Nadu. We have carried out linkage analysis of a majority
of these families using PCR-based microsatellite markers from the
candidate regions of six known MCPH loci. Our analysis showed that
the ASPM gene is a major cause of MCPH in Indian families. The
presence of unlinked families to any of the known MCPH loci in our
dataset suggested the involvement of a seventh locus for this disorder.
We are performing a genome-wide screening of unlinked families to
identify a novel MCPH locus. DNA sequence analysis in MCPH5-
linked families has identified one known and four novel mutations in
the ASPM gene in a homozygous state.
088: X-linked Adrenoleukodystrophy gene
polymorphisms and mutation in Indian population
1Neeraj Kumar, 1S. K. Bansal, 3Veena Kalra, 4S. Aneja,
3Madhuri Behari, 2K. K. Taneja
1V. P. Chest Institute, Dept. of Biochemistry, V. P. Chest Institute,
University of Delhi, Delhi 110007, India, 2Institute of Genomics and
Integrative Biology, Institute of Genomics and Integrative Biology,
Mall Road, Delhi 110007, India, 3All India Institute of Medical
Sciences, Dept. of Pediatrics and Dept. of Neurology, All India
Institute of Medical Sciences, New Delhi 110029, India, 4Lady
Hardinge Medical College, Dept. of Pediatrics, Lady Hardinge
Medical College, New Delhi 110001, India
Objectives: X-linked adrenoleukodystrophy (X-ALD) is the most
frequent inherited peroxisomal neurodegenerative disorder caused by
impairment in peroxisomal b-oxidation of very long chain fatty acids
(VLCFAs) due to mutation in ABCD1 gene which encodes a peroxi-
somal ABC half-transporter (ALDP) involved in import of VLCFA
from cytoplasm to peroxisomes. The study aims at establishing genetic
association of ABCD1 and ABCD2 gene polymorphism with various
phenotypes of X-ALD and identify and classify mutations.
Methods: Nineteen adrenoleukodystrophy patients and 70 unrelated
matched healthy subjects (controls) were enrolled. Patients were
recruited on the basis of MRI and/or VLCFA analysis. Blood was col-
lected, genomic DNA isolated, and PCR for ABCD1 and ABCD2 genes
performed using exon flanking region primers to sequence the exonic
region of the genes by ABI 3100 automated sequencer. Results: We
identified a total of six single nucleotide polymorphisms (SNPs) in
controls and adrenoleukodystrophy patients in both the genes. Five
SNPs include 50 UTR polymorphism C/T at position-59 (frequency
16.67%) and exonic polymorphism G/A at position 1548 in sixth exon
(frequency 18.6%). Two intronic (IVS-1) polymorphisms G/A were
identified at position-105 (frequency 5.4%) and C/T at position-16
(frequency 5.4%) and another novel unique polymorphism G/T at
position-51 in IVS3. One novel polymorphism was also detected C/A in
the ABCD2 gene at position-59 (frequency 23.18%) in IVS4. Addi-
tionally, we have identified two mutations in patient sample, one in exon
at position 796, resulting in change of amino-acid glycine to arginine at
position 266 in protein. Another mutation at 30 splice site in IVS4 is at
position-2. It is denovo as it is not present in the proband mother. SNP
results analysis does not show any significant association with any of the
six polymorphisms in various phenotypes of adrenoleukodystrophy.
Conclusion: ABCD1 and ABCD2 gene polymorphisms alone may not
be important risk factors for adrenoleukodystrophy. More genes like
ABCD3 and ABCD4 may be involved in this complex disease process
whose protein products may interact with the ALDP. The mutation in
splice site in ABCD1 is very interesting. We expected formation of
higher molecular weight cDNA due to splice site mutation. However,
there was no formation of cDNA of the ABCD1 gene, indicating the
aberrant or incomplete splicing which may result in absence or
translation of a defective protein.
089: Application of human genome knowledge
in a tertiary ophthalmic Institution in India
1Govindasamy Kumaramanickavel, 1Vedam Ramprasad,
1Nagasamy Soumittra, 2Derek Nancarrow, 3Parveen Sen,
4Martin McKibbin, 4Grange Williams, 4Chris Inglehearn
1SN ONGC Dept of Gen and Molecular Biology, Vision Research
Foundation, Chennai, Tamil Nadu, India, 2Oncogenomics,
Queensland Institute of Medical Research Foundation, Herston,
Queensland, Australia, 3Department of Medical Retina, Medical
Research Foundation, Chennai, Tamil Nadu, India, 4Section of
Ophthalmology and Neuroscience, Leeds Institute of Molecular
Medicine, St James’s University Hospital, Leeds, UK
Purpose: To determine the application of human genome knowledge
in diagnosis, inheritance and gene mapping in a tertiary ophthalmic
institution in India.
Methods: Microsatellite markers for RB1 gene and X chromosome
and whole genome homozygosity mapping using the Affymetrix 10K
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XbaI Gene Chip and ExcludeAR program were performed on four
different families with three different mendelian diseases—retino-
blastoma, congenital cataract and Leber congenital amaurosis. The
coding exons of the RB1, NHS and lebercilin genes were sequenced
to screen for mutations co-segregating with the phenotype.
Results: Genomic knowledge helped us to (1) track the defective RB1
allele in two different autosomal dominant retinoblastoma families; in
one family the male neonate did not carry the allele, whereas another
unborn child, carried the defective allele and in a two year intense follow-
up showed signs of the tumor; (2) refine clinical diagnosis of a congenital
cataract family to Nance-Horan syndrome and this was possible with the
lab data on this family with linkage to Xp22.13 and identifying a trun-
cating mutation C115T in exon 1 of NHS gene, resulting in conversion of
glutamine to stop codon (Q39X); (3) map the gene in the third family,
this was a second-cousin marriage—there were two girls who were
affected with LCA. In this family analysis revealed two homozygous
regions in both the children for which the parents were heterozygous—
6q12-q16.3 and 7q21.11-q22.3. A 24.5cM region with 139 consecutive
SNPs at 6q12-q16.3 had a homozygous novel c.955G[A missense
mutation in lebercilin in the last base of exon 6, causing disruption of the
splice donor site. This mutation ablates the correct splice donor site,
leading to mis-splicing at an alternative donor site 5 bp into the adjacent
intron, which results in a 5 bp insert in the transcript. This in turn leads to
a frameshift and premature truncation of the protein.
Conclusion: In these four families, genomic knowledge helped us not
only to identify the causative genes but also to help these families in
genetic counseling. These studies had benefited the family and it also
emphasizes the importance of bench to bedside practice.
090: Simple and cost-effective approach
for quantitative detection of heterozygous deletion
genotypes in diagnosis of DMD/BMD carriers
1P. S. Lai, 1S. R. Jada, 1S. Y. Pang, 1O. S. Yim, 1P. S. Low,
1S. K. H. Tay, 2,3E. P. H. Yap
1National University of Singapore, Dept of Paediatrics, National
University Hospital, 5 Lower Kent Ridge Road, Singapore, 2Defence
Research and Technology Office, Ministry of Defence, Singapore,
3Defence Medical and Environmental Research Institute, DSO
National Laboratories, Singapore
Deletions involving whole single or multi-exons of the DMD gene
account for more than half of all patients with Duchenne/Becker
muscular dystrophy (DMD/BMD). A number of techniques are cur-
rently used to identify these mutations routinely. However, the
methods for detecting carriers of deletion or duplication genotypes
either require sophisticated equipment or involve laborious protocols
or expensive kits. Some methods are also susceptible to false deletion
positive results arising from single base deletion or polymorphism
affecting ligation or primer binding site. We compare two dosage
methods for detecting heterozygous deletions within the gene muta-
tion hot-spots in our population. Quantitative real-time assays were
designed covering exons 6, 8, 45 and 50. Reference exon plasmid
constructs were cloned and used to generate standard curves for
validation of amplification efficiencies. Melt curve analysis was used
to rule out non-specific PCR products. Gene dosage analysis showed
that 79.9% of all deletion patients can be screened using this four
exons assay set while addition of another three exons, i.e. 3, 20 and
47, would cover all common gene deletions in our population. We
also carried out analysis using multiplex ligation-dependent probe
amplification (MLPA) which covers all 79 exons. Concordant results
were obtained except for one case of false positive deletion of an extra
exon shown by MLPA screening. Both approaches were useful for
carrier screening in our families. Out of a total of 156 affected
families, 71 were due to deletions of single or multi-exons. Carrier
mothers were detected in 47 families (66.2%), of which 12 (16.9%)
were obligate carriers. Our quantitative real-time exon-specific assay
sets are rapid, reliable and cost-effective for detecting heterozygous
carriers of deletion genotypes. It will also be useful for other ethnic
populations with similar common DMD deletion mutation profiles.
091: Novel CUL7 mutation in 49 Yakut patients
with short stature syndrome
1Nadejda Maksimova, 2Kenju Hara, 2Akinori Miyashita,
1Irina Nikolaeva, 3Anna Nogovicina, 3Aitalina Sukhomyasova,
2Masatoyo Nishizawa, 2Osamu Onodera
1Yakut Scientific Centre, Siberian Department of Russian Academy
of Medical Sciences, 677019 4, Sergelyakhskoye shosse, Yakutsk,
Russia, 2Brain Research Institute, Niigata University, 951-8585 1-757
Asahi-machi-dori, Niigata, Japan, 3Republican Hospital National
Medical Centre, 677019 4, Sergelyakhskoye shosse, Yakutsk, Russia
Yakuts have a high frequency of some hereditary diseases, because
they have experienced a serious bottleneck effect. Hereditary short
stature syndrome is one of the major concerns in Yakuts. We have
identified 49 patients with short stature syndrome in 43 Yakut
families with pre- and post-natal non-progressive growth failure,
facial dysmorphism and normal intelligence. The average of birth
length was 42.0 cm ± -6.2 standard deviation score (SDS), and
that of weight was 2.330 kg. A genome-wide linkage analysis for
these families revealed linkage to region 6p21.1 with the highest
multipoint LOD score of 24.6 at D6S282. We applied a homozy-
gosity mapping approach and narrowed the causative gene to the
same locus of the 3-M syndrome and the gloomy face syndrome
(Huber et al., 2005). We found a novel homozygous 4582insT
mutation in CUL7, which resulted in a frameshift and subsequent
premature stop codon at 1553 (Q1553X). The clinical presentations
of 49 patients with short stature syndrome (from birth to 45 years)
in Yakut were similar to those of 3-M syndrome. However, they
have a high frequency of neonatal respiratory distress (41.98%) and
a low frequency of X-ray abnormalities. These findings may provide
better understanding of the clinical diversity of short stature syn-
drome with the CUL7 mutation.
092: SCA-LSVD: A new locus specific disease database
(LSDB) for cataloging variations associated
with Spinocerebellar ataxias
1,2Faruq Mohammed, 1Vinod Scaria, 2Inder Singh,
2Achal Srivastava, 1Mitali Mukerji
1Institute of Genomics and Integrative Biology, CSIR, Mall Road,
Delhi, India, 2All India Institute of Medical Sciences,
New Delhi, India
Spinocerebellar ataxias (SCAs) are a group of neurodegenerative
disorders clinically and genetically heterogeneous, characterized by
overlapping clinical symptoms among subtypes that include pro-
gressive gait ataxia, dysarthria, pyramidal and extrapyramidal signs
peripheral neuropathy, ophthalmoplegia. Nearly 30 loci have been
identified to be associated with ataxia which includes both candidate
linkage regions as well as well characterized genes. Repeat expan-
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sions in 10 of the characterized loci have been associated with SCA.
Due to a wide clinical spectrum of SCAs and overlapping features, the
clinical classification becomes difficult in the absence of genetic
analysis. Therefore, an understanding of Phenotype to Genotype
correlations in SCAs would be integral in clinical diagnosis, and
planning optimal treatment/disease management strategies. As a step
towards this we have created a new locus specific variation databases
for SCAs (SCA-LSVD) aims to catalog and integrate information on
SCAs from all over the world. Currently, the database houses detailed
information on the clinical features like age at onset, symptom at
onset, mode of inheritance, and besides repeat length also harbors
information on SNP variations, genotypes and haplotypes associated
with the affected individuals from more than 450 families across
India. Amongst the genetically characterized loci only five of them
has so far been observed to be associated with SCA in India
accounting for nearly 40% of the SCAs. Amongst these, SCA2 has the
highest frequency (33%) followed by SCA12 (30%), SCA1 (21%),
SCA3 (10%), SCA7 (2%). Preliminary Genotype-Phenotype corre-
lations of the ataxias reveal subtle features that distinguish SCA
subtypes with overlapping cerebellar features. For instance, individ-
uals of SCA12 have a characteristic tremor not observed in other
ataxias and is specific to an ethnic population. Once a close link with
tremor, ethnicity and SCA12 has been established, it is much easier to
clinically classify SCA12. This would be a very useful starting point
for understanding the molecular correlates of phenotypes in ataxia
which is a multi locus disease where related molecular mechanisms
converge to overlapping phenotypes. SCA-LSVD would also be an
important resource to identify novel candidate loci for SCAs. This
database would be soon made available online and would allow
submission and viewing of variants associated with SCA.
093: Heterozygous deletion of the 30 region of TYR
is one of the potential mutations which remains
uncharacterized in 15% of the OCA1 patients
worldwide
1Maitreyee Mondal, 1Mainak Sengupta, 1Moumita Chaki,
2Swapan Samanta, 1Kunal Ray
1Molecular and Human Genetics Division, Indian Institute
of Chemical Biology (CSIR), Kolkata, India, 2Department
of Ophthalmology, Calcutta National Medical College, Kolkata, India
Oculocutaneous albinism type 1 (OCA1) is an autosomal recessive
hypopigmentary disorder, associated with common developmental
anomalies of eye. Currently, almost 200 mutations of Tyrosinase
gene (TYR, 11q14.2) are known that results in pathogenic conditions
of OCA1, but in 15% of the patients, the second mutation has never
been identified. We recently proposed that partial deletion of 30-
region of TYR, which has *98.55% sequence identity with a known
pseudogene (TYRL, 11p11.2-cen), could represent such ‘unidentified
mutations’ (UCMs); since commonly used PCR-based mutation
screening would not detect heterozygous gene deletion (Prog Retin
Eye Res 26: 323–358, 2007). Therefore, we examined our OCA1
patient pool for heterozygous deletion of the 30-region of TYR. We
studied two unrelated OCA patients in which, the second mutation
in TYR could not be identified despite screening the entire coding
sequence, splice junctions and promoter region of the gene. Using
limited amount of genomic DNA from these two samples, we
amplified the 30-region of TYR by semi-quantitative PCR with
fluorescent-labeled primers, followed by assessment of the gene
products via genemapper software (Applied Biosystems). The results
suggested heterozygous deletion of TYR in one patient, previously
identified as a heterozygote for Arg278stop (R278X) at TYR locus.
A SNP based assay is currently being implemented to corroborate
our finding. A positive result would support our hypothesis that
heterozygous gene deletion represents at least some of the refractory
mutations in TYR, currently known as ‘UCMs’ in 15% of the OCA1
cases worldwide. Also, we propose that the patients lacking the
second TYR mutations should be screened for heterozygous gene
deletion. This study is supported by funds from Council of Scientific
and Industrial Research (CSIR), Govt. of India.
094: Mitochondrial gene mutations as a cause
of non-syndromic hearing impairment among probands
from Andhra Pradesh
1G. Padma, 1T. Padma, 2P. V. Ramchander, 3U. V. Nandur
1Department of Genetics, Osmania University, Hyderabad, India,
2Institute of Life Sciences, Bhubaneshwar, Orissa, India, 3Govt. ENT
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Hearing impairment affecting 1 in 1,000 newborns is a highly heter-
ogeneous disorder with majority of the cases being non-syndromic
(NSHI). It can result from a mutation in a single gene or from a
combination of mutations in different genes or by environmental
factors and also by interaction between genetic and environmental
factors. Mitochondrial DNA mutations have been found to be asso-
ciated with both aminoglycoside induced hearing impairment and
NSHI. The common mtDNA mutations causing NSHI include
A7445G, T7510C, T7511C in tRNA Ser (UCN) gene and A1555G in
12S rRNA gene. This mutation is more frequent in many populations
and is considered as a primary factor underlying the development of
deafness. However, the expression of the deafness phenotype associ-
ated with this mutation requires contributions of nuclear modifier
genes or aminoglycoside antibiotics which affect the phenotypic
manifestation by enhancing or suppressing the biochemical effect of
the mutation. A nuclear modifier gene on chromosome 8 is thought to
account for deafness in those individuals who do not have amino-
glycoside exposure. 484 probands with profound bilateral
sensorineural hearing impairment were ascertained for various epi-
demiological parameters and 303 DNA samples of patients including
25 families and 200 control samples were screened for mitochondrial
mutations by PCR–RFLP followed by genotyping on 2% agarose gels
stained with ethidium bromide. The epidemiological results revealed:
preponderance of males (58.7%) as compared to females (41.3%)
indicating high risk for hearing impairment in males. High incidence
of positive family history (59.9%), parental consanguinity (58.0%) and
delayed milestones (59.5%) was recorded in males as compared to
females. 32.6% of the cases with delayed milestones were considered
as due to vestibular dysfunction. Screening for mutations revealed
absence of A7445G, T7510C and T7511C in tRNA Ser (UCN) gene.
Three homozygous mutants were found for A1555G mutation in 12S
rRNA gene. All the three probands had profound non-syndromic
hearing impairment and had no history of exposure to aminoglycoside
antibiotics suggesting the possible involvement of nuclear modifier
gene that might interact with the mutated 12SrRNA and affect the
phenotypic manifestation by enhancing or suppressing the biochemi-
cal effect of the mutation. None of the controls showed the mutation.
This is the first study from India showing the prevalence of A1555G
mutation among non-syndromic hearing impaired patients.
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095: Seven new mutations have been found in STX11,
PRF1 and UNC13D genes in a group of Russian FHL
patients
1N. V. Poltavets, 2M. A. Maschan, 1V. V. Zabnenkova,
1A. V. Polyakov, 2G. A. Novichkova, 2A. A. Maschan
1Research Center for Medical Genetics, Russian Academy of Medical
Sciences, Moscow, Moscvorechie, 1, Russia, 2Federal Research
Clinical Center for pediatric, Moscow, Leninskiy pr., 117, Russia
FHL is a rare recessive disorder of immune regulatory pathways.
X-linked lymphoproliferative syndrome (XLP) caused by EBV may be
pathologically indistinguishable from FHL. FHL-causing mutations
have been found in PRF1 (10q22), UNC13D (17q25.1) and STX11
(6q24.1) genes. These genes code proteins involved in the lymphocyte
cytotoxity. XLP-causing mutations have been found in SH2D1A (Xq)
and XIAP (Xq) genes. We have investigated a group consisted of 18
unrelated Russian patients. The disease manifestation age ranged from
a few days to 9 years. DNA samples have been investigated for
mutation in PRF1, UNC13D and STX11 genes coding areas by direct
sequencing. In the cases when mutations have not been detected in
these genes and X-linked inheritance could not be ruled out we have
investigated SH2D1A gene. Investigation of UNC13D gene has
detected 6 compound heterozygote patients, carring two mutations, 1
homozygote patient carrying one mutation and one patient carrying
only 1 mutation in heterozygote state. Four frame shift mutations have
been detected: c.627delT on one chromosome, c.1828insA on two
chromosomes (new), c.2346_2349delGGAG on three chromosomes
and c.3037insG on five chromosomes (new) in UNC13D gene. A new
mutation c.2216_2239del on one chromosome, one previously repor-
ted splicing mutation c.322-1G[A on one chromosome and one new
possible missense mutation c.3173T[C (p.1058Leu[Pro) on one
chromosome have been also found in UNC13D gene. Two mutations
have been detected with higher frequency (c.2346_2349delGGAG on
three chromosomes and c.3037insG on five chromosomes) so we
propose that there might be ‘hot points’ in UNC13D gene. One patient
has been found to carry a new mutation (c.675_679del/c.675_679del)
in STX11 gene in homozygote state. Nucleotide substitutions have
been detected on 3 chromosomes in PRF1 gene. One new nonsense
mutation c.1283G[A (p.428TRp[Stop) and two possible new mis-
sence mutations c.1000G[A (p.334Gly[Ser) and c.916G[T
(p.306Gly[Cys) have been found. Among patients carrying no muta-
tions in cording area of PRF1, STX11 and UNC13D genes one
hemizygote patient carrying mutation c.164G[T (p.55Arg[Leu)
CD01961 in SH2D1A gene have been detected. Genetic lesions have
been detected in over 60% of FHL patients: eight patients (44%) car-
ried mutations in UNC13D gene, two patients (11%) carried mutations
in PRF1 gene and one patient (6%) carried mutation in STX11 gene.
According to these results it is possible to consider UNC13D to be the
first candidate gene in the group of Russian FHL patients.
096: Genetic polymorphism and expression analysis
of Glutathione S-Transferases in breast cancer patients
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Recent reports have revealed the increased incidence of breast cancers
with industrialization and urbanization in many countries, including
India. Glutathione S-transferases (GSTs) are a large family of proteins
that participate in antioxidant defenses and xenobiotic detoxification.
They occur both in cytosol and microsomes. Eipdemiological studies
have revealed that individuals with null genotypes for GSTM1 and
GSTT1 are associated with many adverse health effects, including
risk of developing cancer of bladder, colon, lung, skin and stomach.
The studies clearly demonstrate that lack of expression of certain
isoforms of GSTs make the individuals susceptible for cancers
induced by toxic chemicals. In the present study we examined the
possible correlation of GST gene polymorphism and breast cancer
incidence using data from breast cancer patients undergoing treatment
at Indo-American cancer hospital and MNJ cancer hospital in Hy-
derabad, India. Also studies were conducted on the pattern of changes
in GSTs in cancerous and adjacent non-cancerous tissues obtained
from breast cancer patients undergoing surgery. DNA was extracted
from blood samples and genotyped for GSTM1, GSTT1 and GSTP1
gene deletion using multiplex PCR. These studies revealed higher
frequency of GSTM1 gene deletion in breast cancer patients (38%;
n = 36) compared to normal individuals (26%; n = 15), suggesting a
possible correlation of GST M1 gene deletions and breast cancer risk.
Further studies on the expression of GSTs revealed a significantly
higher expression of GST Pi with no appreciable changes in GST
alphaand GST Mu tissues (n = 24) compared to the corresponding
normal tissue (n = 24). Along with the elevation of GST-Pi levels,
high molecular weight proteins (470 KDa) cross reacting with GST
antibodies were detected only in surgically desected tumor biopsies
but not in non-cancerous tissues adjacent to the tumor. Based on
MALDI-TOF analysis, the high molecular weight band were identi-
fied as synaptotagmin V bound to GST-M1 with 47% sequence
coverage after processing on an MS-FIT search engine. In conclusion,
our studies reveal an association between GST M1 gene deletion and
breast cancer risk and over expression of GSTPi in cancer tissues.
Further studies are needed to understand the functional role of GST-
synaptotagmin complex in human breast cancers.
097: Identification of disease causing mutations
in Familial Hypertrophic Cardiomyopathy patients
from Andhra Pradesh
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Familial Hypertrophic Cardiomyopathy (FHC) is an autosomal domi-
nant inherited disorder of the cardiac sarcomere characterized by left
ventricular hypertrophy and myocyte and myofibrillar disarray with
variable clinical and morphologic expression. It is the most common
cause of sudden death in otherwise healthy young athletes. Gene
association studies and linkage analysis have led to the identification of
at least 12 genes responsible for the development of FHC. It is important
to establish genetic and clinical status of patients in India. We have
investigated disease causing mutations selectively in MYH7 and
MYBPC3 genes, which are frequently involved in FHC in the western
population. To date, we have identified six mutations, one in the MYH7
gene and five in the MYBPC3 gene, including one novel splice site
mutation in 19th intron of the MYBPC3 gene. The p.R787H mutation in
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the MYH7 gene was identified in four families though it could be a
sporadic mutation in two families. We have analyzed the clinical pre-
sentation of 12 members from the four families harboring the p.R787H
mutation and the results revealed a wide clinical heterogeneity. There
does not appear to be a significant correlation of the clinical heteroge-
neity with age, gender and angiotensin converting enzyme (ACE) gene
polymorphism. We have carried out sequence and structural analyses
of the mutant MYH7 protein, in order to understand the molecular basis
for the pathogenic affect of the p.R787H mutation. Our results indicate
that the Arginine to Histidine mutation may affect the binding of the
myosin heavy chain to the myosin essential light chain thereby com-
promising muscle contraction. We also identified the p.C1123ter
mutation in the MYBPC3 gene in a 3-year-old child. The mother and
elder female sibling of the proband also harbored the mutation but were
asymptomatic, indicating a possible role of modifier gene(s) such as
ACE. It is our endeavor to delineate disease causing mutations in FHC
patients in order to develop molecular diagnostic strategies and to carry
out genotype phenotype correlation analysis, which will help clinicians
to provide better patient management and genetic counseling.
098: Molecular heterogeneity of Beta-thalassaemia
and associated disorders in multiethnic setting
of Southern Bengal, India
B. N. Sarkar, Subhra Bhattacharya, Sujit Mallick, Tapas Biswas,
K. Das, Sikha Chatterjee, V. R. Rao
Anthropological Survey of India, 27 Jawaharlal Nehru Road,
Kolkata-700016, India
Introduction: Beta thalassaemia is one of the inherited genetic disorders
caused by mutations of the Beta-globin gene and poses a major health
and socio-economic burden in the Mediterranean region, Middle-east,
Indian subcontinent, Burma and in South–east Asia. India presents an
alarming picture with respect to the frequency distribution of the dis-
eased phenotypes as well as the carriers. The double heterozygous
condition like E-Beta-thalassaemia is also the commonest type of
thalassaemia in eastern part of India, Burma and Southeast Asia.
Objectives: The Anthropological Survey of India, in view of severity
and the limited scope for management of the disease, has initiated a
community genetic approach through mass awareness and massive
population-screening program as the preventive measure. The objective
of the present study is to identify the Beta-Thalassaemia mutations and
other abnormalities in multiethnic setting of southern Bengal.
Methods: More than 5,000 unrelated individuals aged 13–30 years from
the coastal South 24-Parganas district of West Bengal have participated
in the mass screening drive for beta thalassaemia under the Community
Genetics Extension Program. The methods used for the present study
were CBC, HPLC, ARMS-PCR and sequencing of beta-globin gene.
The haplotype patterns of the mutations were also detected by RFLP.
Results and Conclusion: The label of awareness in the studied area was
very poor. Altogether 13.7% of the subjects were identified to carry
abnormalities of hemoglobin in one or other forms. The IVSI-nt5-G[C
was found to account for about 75% of all the mutations, followed by
cd41/42 (-TCTT), cd15 (G[A) and others. In high-risk zones like
eastern India this prospective premarital screening would be an ideal
approach for preventing haemoglobinopathies and thalassaemic births.
099: Molecular characterization of oculocutaneous
albinism Type 1 (OCA1) mutations found in Indian
population
1Mainak Sengupta, 1Moumita Chaki, 1Maitreyee Mondal,
2Swapan Samanta, 1Kunal Ray
1Molecular and Human Genetics Division, Indian Institute of
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Oculocutaneous albinism (OCA), which results in congenital hypo-
pigmentation of ocular and cutaneous tissues, is reported as one of the
four major causes of childhood blindness in India. Tyrosinase (TYR)
being the key enzyme in the first two rate-limiting steps of melanin
(pigment) biosynthesis, we selected it as the first candidate to investi-
gate the molecular basis of OCA in the 50 Indian pedigrees. We
detected 4 reported and 8 novel pathogenic changes in TYR and the
results suggested that*50% of OCA patients harbour TYR mutations
(i.e. OCA1 cases) as a result of founder effect. To decipher the
molecular basis of OCA1 pathogenesis, the missense mutations were
introduced in normal TYR cDNA clone by site-directed mutagenesis,
expressed in HEK293 cells and and their enzymatic activities (both
tyrosine-hydroxylase and DOPA-oxidase) were measured. Biochemi-
cal assays revealed that, compared to the wildtype protein, all the
mutants were almost devoid of any enzymatic activity. However,
western blot analysis detected similar protein levels in wildtype as well
as mutants, except two, where the mutant proteins were drastically
reduced; mRNA expression studies are underway with these two
mutations. Next, to explore the processing defect of TYR mutants at the
subcellular level affecting enzymatic activity of the protein, immuno-
histochemical studies were carried out with appropriate ER and Golgi
markers; which suggested ER retention of three TYR mutants. Cur-
rently immunoprecipitation and Endoglycosidase H digestion are being
pursued to confirm our result. This study is supported by funds from
Council of Scientific and Industrial Research (CSIR), Govt. of India.
100: NPHS2 and WT1 mutations in Indian children
with steroid-resistant nephrotic syndrome
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Introduction: Steroid resistant nephrotic syndrome (SRNS) is a heter-
ogeneous disease, characterized by heavy proteinuria and renal failure.
Mutations of NPHS2 and WT1 genes, lead to early onset of heavy
proteinuria and rapid progression to end-stage renal disease. In this
study, we investigated the prevalence of NPHS2 and WT1 mutation
among Indians and their association with clinical outcomes
Method: For this study we enrolled 40 children with sporadic SRNS
and 40 steroid sensitive nephritic syndrome subjects as control. Renal
biopsy in SRNS patients revealed mesangial proliferative glomeru-
lonephritis (n = 8), focal segmental glomerulosclerosis (FSGS;
n = 16), and minimal change disease (n = 16). The mean age of
onset of SRNS was 4.65 years. Mutation analysis was performed by
conformation sensitive gel electrophoresis of all exons of NPHS2 and
WT1 gene. PCR products were screened for sequence alteration by
CSGE. If an aberrant band was detected by CSGE, the corresponding
PCR product was sequenced. Common NPHS2 variant R229Q was
detected by restriction digestion of exon 5 PCR product with ClaI
restriction enzyme.
Result: Mutations were identified in 6 (15%) patients. We found
compound heterozygous mutation R229Q and R322P in NPHS2 in
one patient with MesPGN. Three patients with FSGS were found to
have R229Q in heterozygous condition. One patient with FSGS was
heterozygous for 4 bp deletion TAAT in exon 5 of NPHS2 gene
leading to frame shift. R322P and 4 bp deletion are novel changes.
One female patient with FSGS had IVS9?4C[T in WT1 gene and
karyotyping revealed complete sex reversal with 46, XY genotype.
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Out of these six patients three responded to tacrolimus and three
responded to cyclosporine.
Conclusion: In this ongoing study we have detected mutations in
significant number of patients. Our study demonstrated that mutation
in NPHS2 and WT1 are also present in Indian patients with SRNS.
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Background: Congenital insensitivity to pain (CIP) syndrome is one of
the rare hereditary sensory autonomic neuropathies. We characterized a
Beduin family from the Negev, in which three individuals suffer from
this disease.
Aim: To identify the mutation which causes the disease.
Methods: A SNP genotyping using the GeneChip mapping 250K array
was performed with samples from the three affected individuals and
one unaffected parent in the family. Homozygosity mapping and
sorting of genomic regions were performed with software specially
programmed for this purpose. Several regions were selected upon their
physical size and number of SNPs they contain. These regions were
genotyped for all members of the family with microsatellite markers
and linkage was found to one region. Sequencing of the genes in the
interval was done to identify the mutation causing the disease.
Results and Conclusions: We have mapped the locus to a 14.2Mb
region on chromosome 2q. Screening of candidate genes in this region
identified a protein-damaging mutation in SCN9A gene, which
encodes for the voltage-gated sodium channel Nav1.7. This mutation
was not found in 130 healthy Beduins.
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Introduction: X-ALD is the most frequent peroxisomal disorder. It is
caused by mutations in ABCD1 gene. Its symptoms include deterio-
ration in school performance, behavioral disturbances, impaired
vision and hearing, dementia, speech difficulty and urinary inconti-
nence. Diagnosis of ALD is suspected by clinical, radiological and
biochemical findings (high plasma VLCFA levels). Mutation analysis
is the only method for confirmation of ALD. Data on mutation studies
from India are lacking.
Objectives: To do mutation analysis of Indian ALD patients.
Methods: 2ml of blood was taken in heparin tube (for VLCFA anal-
ysis) and 5ml of EDTA blood (for mutation analysis) from the patients
who were clinically and radiologically suspected of ALD. Eleven
Patients who have high plasma VLCFA levels were enrolled and
subjected for mutation analysis. Primers were specifically selected to
avoid amplification of fragments of the 30 partial pseudogene and all
the 10 exons comprising the coding region of ABCD1 gene were
amplified using polymerase chain reaction. Conformation sensitive gel
electrohoresis (CSGE) was standardized for mutation screening.
Finally, sequencing was done in Patients found positive by CSGE.
Results: Out of 11 patients, mutations were found in seven patients.
Three novel mutations (67_83del17 in exon 1, IVS4-2A[G in intron
4, 1939_40insGG in exon 9) and three known mutations (1202G[A in
exon 3, 1547T[C in exon 6, 1679C[T in exon 7) were found. One of
the mutations (1679C[T) was found in two patients.
Conclusion: ABCD1 gene mutation analysis helps in correct diag-
nosis of ALD, facilitates prenatal diagnosis, carrier detection and
ensures proper genetic counseling.
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Hereditary retinal degenerations or dystrophies are a group of disor-
ders characterized by inherited, progressive degeneration and death of
retinal tissue. They are clinically and genetically heterogeneous and
primarily involve degeneration of retinal photoreceptors. Retinitis
pigmentosa is one of the major forms of retinal degeneration with at
least 50 genes identified so far in affected families. In order to conduct
a screen of known disease loci in families with recessive RP, we used
an approach of screening for homozygosity at candidate gene loci in
affected individuals. 34 families with autosomal recessive RP (ARRP)
and related disorders were included in the study of which 25 families
were consanguineous. Patients and family members were clinically
evaluated and blood samples were collected for DNA extraction after
obtaining consent. Microsatellite markers flanking 23 known candi-
date genes for retinal dystrophy were genotyped in available members
of all families. Families in which homozygosity was detected in all
affected members at a given gene locus were further screened for
mutations in the relevant gene. Coding regions of the genes were
amplified using exon-specific primers and subjected to direct
sequencing. Screening of 23 gene loci revealed homozygosity in
affected individuals of 10/34 families. The loci are at chromosomes
6p21.3, 1p22.1, 1p31, 4p16.3, 1q31, 4p12, 15q26, 8q11, 14q11, 1q31,
10q23. Mutation screening in the relevant candidate genes revealed
homozygous mutations that are possibly pathogenic. This approach
relies on the presence of consanguinity and enabled a rapid pre-
liminary screen of known loci in a genetically heterogeneous disorder.
104: Origin of Friedreich’s ataxia (FRDA) mutation
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Friedreich’s ataxia (FRDA) is an autosomal inherited recessive ataxia
caused by expansion of GAA repeats in the intron 1 of frataxin gene.
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The GAA repeats polymorphic in the normal individuals are restricted
to a threshold which varies in length from 7 to 16. Once unstable
these repeats expand from 120 to over thousand repeats in the
affected individuals. Haplotype analysis has revealed that expanded
alleles arise through an intermediate premutation stage from large
normal alleles (LNs) of GAA repeat ([12) and the frequency of the
LNs determine prevalence of FRDA in a population. In this study,
we have undertaken a detailed haplotype analysis of 23 FRDA
families which had tested positive for homozygous GAA expansion
and 200 ethnically matched normal individuals of Indian origin. The
families though inhabitants of diverse geographical regions were all
of Indo-European (I.E) origin. An earlier study by the Indian Gen-
ome Variation Consortium has revealed that I.E populations are
genetically closer to CEU in HAPMAP. Therefore, we undertook
this analysis using tag SNPs derived from CEU population. These
SNPs span a 200 kb region encompassing the GAA repeat and also
include two SNPs (ITR3-rs3829062; FAD1-rs11145465) which have
earlier been associated with GAA expanded alleles in the French
population as well as few Indian families of eastern India. We
observed a significant association (p \ 10-6) of four SNPs
rs3829062 (93%), rs11145326 (93%), rs7861997 (79%) and
rs11145465 (73%) with the expanded alleles. The SNPs rs3829062
and rs11145465 have been significantly associated with expanded
alleles in French population with frequencies of 100 and 90%,
respectively. These results suggest that Indian and French population
share a common founder which predates divergence of these pop-
ulations. Compared to 17% frequency of LNs in French population
we observed its frequency to be 4.8% in the Indian population. This
correlates with differences in FRDA prevalence between the two
populations. The haplotype associated with the LNs in Indian pop-
ulation is also shared with the expanded alleles. It would be
interesting to determine whether the expanded alleles have arisen
from de novo recurrent mutations of LNs in the Indian population or
through admixture with the CEU population.
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Purpose: Retinitis pigmentosa (RP) and Leber congenital amaurosis
(LCA) are, respectively, the commonest and the most severe retinal
dystrophies causing blindness. Over 40 genes in RP and 13 genes in
LCA, have been implicated. Only affecteds from three consanguineous
families, affected with severe childhood onset retinal dystrophy were
studied to identify the disease causing genes.
Methods: A thorough ophthalmic examination that included electro-
retinogram, fundus photograph was carried out on affected and
unaffected family members and homozygosity mapping was per-
formed using the Affymetrix 10K Xba1 GeneChip and ExcludeAR
program. Based on the homozygosity results the coding exons of the
lebercilin and CERKL genes were sequenced to screen for mutations
co-segregating with the phenotype.
Results: Family I had two affected children, but the second child
aged 11 months died due to asphyxia. Analysis using EXCLUDE
AR spread sheet program identified a significant 24.5cM homozy-
gous region at 6q12-q16.3, both the affecteds had a homozygous
novel c.955G[A missense lebercilin (LCA5) mutation in the last
base of exon 6, causing disruption of the splice donor site. This
mutation ablates the correct splice donor site, leading to mis-splicing
at an alternative donor site 5 bp into the adjacent intron, which
results in a 5 bp insert in the transcript. This in turn leads to a
frameshift and premature truncation of the lebercilin protein. Family
II also with two affecteds had only one significant 55.5cM homo-
zygous region identified at 2q24-2q33, overlapping the previously
characterized RP26 locus. The gene implicated in RP26-Retinitis
pigmentosa, CERKL, did not show any mutation. The affected
consanguineous family III had 5 members affected with recessive
retinitis pigmentosa. Homozygosity analysis revealed a 30 cM sig-
nificant homozygous region at 6p21.1-12.3 which has not been
reported so far.
Conclusions: Genome wide homozygosity mapping using oligonuc-
leatide SNP arrays is a simple, rapid method to locate genes
underlying recessively inherited disease in consanguineous families.
In this way a novel lebercilin mutation was identified in an LCA
family. The respiratory related pathology in the deceased child could
be the result of a defect in the primary cilia. More significantly two
new loci harboring retinal dystrophy genes which have not been
reported so far have been identified.
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Thalassaemia is a public health problem in Malaysia where 4.5% of
Malaysian Chinese are a0-thalassaemia carriers and about 3.5–4.5% of
the population are carriers for b-thalassaemia. Individuals with double
heterozygosity for a- and b-thalassaemia and heterozygous b-thalas-
saemia show a similar haematological picture. Co-inheritance of
a- and b-thalassaemia in both partners may result in pregnancies with
either Hb Bart’s hydrops foetalis or b-thalassaemia major, or preg-
nancies with both disorders. Therefore, a study on the co-inheritance of
a-thalassaemia in 322 b-thalassaemia carriers (Chinese, Malay, Indian
and indigenous population) was carried out. The frequency of a-thal-
assaemia in the b-thalassaemia carriers was 12.7% (41/322), with a
carrier frequency of 7.8% for the SEA deletion, 3.7% for the a3.7
deletion, 0.9% for Hb Constant Spring and 0.3% for the a4.2 deletion.
Double heterozygosity for a- and b-thalassaemia was confirmed in five
out of the 41 couples and the risk of Hb Bart’s hydrops foetalis was
confirmed in two of these couples. Detection of the SEA deletion in the
Malaysian Malays in this study confirms that Hb Bart’s hydrops foe-
talis can occur in this ethnic group. Results from this study have
provided new information on the frequency and different types of a-
thalassaemia in Malaysian b-thalassaemia carriers.
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Thalassemia is one of the most prevalent hemoglobinopathies in Ban-
gladesh. A recent study shows that about 4.1% of Bangladesh
population are carriers of b-thalassemia trait and affected b-thalassemia
birth per thousand is 0.106. However, there is no systemic information
on the genetic background of the disease in Bangladesh. In an attempt to
reveal different b-globin mutations associated with b-thalassemia as
well as to find a correlation between different mutations and phenotypic
severity in Bangladesh population, we screened significant number of
thalassemic patients in molecular level to find the underlying genetic
mutations. We amplified and sequenced the genomic region considered
to be most prone to mutations in thalassemic patients throughout the
world population. Our study has revealed several mutations. Some of
these corroborate with findings made on other populations. However,
some mutations appear to be novel.
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